|
Publicaciones científicas en Inglés. 2013
Modrego H, Azcona L, Martín-Palacios N, Zamorano-León JJ, Segura A, Rodríguez P, Guerra R, Tamargo J, Macaya C
Platelet content of nitric oxide synthase 3 phosphorylated at serie is associated with the functional response of platelet to aspirin
PlosOne 2013;8(12):e82574. doi: 10.1371/journal.pone.0082574. Dolz-Gaitón P, Núñez M, Núñez L, Barana A, Amorós I, Matamoros M, Pérez-Hernández M, Pérez-Hernández M, González de la fuente M, Álvarez-López M, Macías-Ruiz R, Tercedor-Sánchez L, Jiménez-Jaímez J, Delpón E, Caballero R, Tamargo J.
Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada Syndrome with variable expression in a spanish family
PlosOne 2013 8(11):e81493
Zarzuelo MJ, López-Sepúlveda R, Sánchez M, Romero M, Gómez-Guzmán M, Ungvary Z, Pérez-Vizcaíno F, Jiménez R, Duarte J
SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging.
Biochem Pharmacol. 2013 May 1;85(9):1288-96. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden
C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ,
Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice
Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean
V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti
J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P,
Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document
Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C,
Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai
D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni
AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG,
Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL.
2013 ESC guidelines on
the management of stable coronary artery disease: The Task Force on the
management of stable coronary artery disease of the European Society of
Cardiology.
Eur Heart J. 2013 Oct;34(38):2949-3003.
Authors/Task Force Members, Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F,
Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L,
Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto
J, Valensi P, Zamorano JL; ESC Committee for Practice Guidelines (CPG), Zamorano
JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard
R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P,
Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL,
Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, De Backer G,
Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H,
Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, W Hoes
A, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J,
Ponikowski P, Reiner Z, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg
A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG.
ESC Guidelines
on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration
with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular
diseases of the European Society of Cardiology (ESC) and developed in
collaboration with the European Association for the Study of Diabetes (EASD).
Eur
Heart J. 2013;34(39):3035-87. doi: 10.1093/eurheartj/eht108.
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T,
Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T,
Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder
RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members.
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task
Force for the management of arterial hypertension of the European Society of
Hypertension (ESH) and of the European Society of Cardiology (ESC).
J Hypertens.
2013 Jul;31(7):1281-357.
doi: 10.1097/01.hjh.0000431740.32696.cc. European Society of Cardiology (ESC); European Heart Rhythm Association
(EHRA), Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G,
Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW,
Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE.
2013 ESC
guidelines on cardiac pacing and cardiac resynchronization therapy: the task
force on cardiac pacing and resynchronization therapy of the European Society of
Cardiology (ESC). Developed in collaboration with the European Heart Rhythm
Association (EHRA).
Europace. 2013 Aug;15(8):1070-118.
doi:
10.1093/europace/eut206.
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt
OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq
C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE; ESC Committee for Practice
Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean
V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti
J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P,
Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document
Reviewers, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bänsch D,
Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand
S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM,
Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson
CM.
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy:
the Task Force on cardiac pacing and resynchronization therapy of the European
Society of Cardiology (ESC). Developed in collaboration with the European Heart
Rhythm Association (EHRA).
Eur Heart J. 2013 Aug;34(29):2281-329.
doi:
10.1093/eurheartj/eht150.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T,
Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T,
Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder
RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A,
Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca
A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S,
Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R,
Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A,
Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M,
Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M,
Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere
M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V,
Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D,
Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA,
Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de
Borne P, Vlachopoulos C, Volpe M, Wood DA.
2013 ESH/ESC guidelines for the
management of arterial hypertension: the Task Force for the Management of
Arterial Hypertension of the European Society of Hypertension (ESH) and of the
European Society of Cardiology (ESC).
Eur Heart J. 2013 Jul;34(28):2159-219.
doi:
10.1093/eurheartj/eht151. Zarzuelo MJ, Gómez-Guzmán M, Jiménez R, Quintela AM, Romero M, Sánchez M,
Zarzuelo A, Tamargo J, Pérez-Vizcaíno F, Duarte J.
Effects of peroxisome
proliferator-activated receptor-β activation in endothelin-dependent.
hypertension.
Cardiovasc Res. 2013 Sep 1;99(4):622-31.
doi: 10.1093/cvr/cvt152. American College of Cardiology Foundation; American Heart Association; European
Society of Cardiology; Heart Rhythm Society, Wann LS, Curtis AB, Ellenbogen KA,
Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ,
Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB,
Ellenbogen KA, Halperin JL, Le Heuzey J, Kay GN, Lowe JE, Olsson SB, Prystowsky
EN, Tamargo JL, Wann LS. Collaborators: Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis
LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman E, Pressler SJ, Sellke FW,
Shen WK. Wisconsin Heart and Vascular Clinic, Department of Cardiovascular Medicine, USA.
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC
and 2011 ACCF/AHA/HRS recommendations): a report of the American College of
Cardiology/American Heart Association Task Force on practice guidelines
Circulation. 2013 May 7;127(18):1916-26.
doi: 10.1161/CIR.0b013e318290826d
Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D,
Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Wann
LS, Curtis AB, Ellenbogen KA, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT,
Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE,
Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Le Heuzey JY, Kay GN, Olsson SB,
Prystowsky EN, Tamargo JL, Wann S.
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC
and 2011 ACCF/AHA/HRS recommendations): a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines
J Am Coll Cardiol. 2013 May 7;61(18):1935-44
doi: 10.1016/j.jacc.2013.02.001
Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC), Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Sousa Uva M, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL; European Association for the Study of Diabetes (EASD).
ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD
Kardiol Pol. 2013;71 Suppl 11:S319-94
Amorós I, Dolz-Gaitón P, Gómez R, Matamoros M, Barana A, de la Fuente MG, Núñez
M, Pérez-Hernández M, Moraleda I, Gálvez E, Iriepa I, Tamargo J, Caballero R,
Delpón E
Propafenone blocks human cardiac Kir2.x channels by decreasing the negative
electrostatic charge in the cytoplasmic pore
Biochem Pharmacol. 2013 Jul 15;86(2):267-78.
doi: 10.1016/j.bcp.2013.04.023 |
|
|
